In this article

President Donald Trump on Thursday struck landmark deals with Eli Lilly

and Novo Nordisk

to slash the prices of their blockbuster weight loss drugs.

Under the agreements, the monthly out-of-pocket cost of popular injections and upcoming pills could range from $50 to $350 starting next year, depending on the dosage and insurance coverage a patient has, Trump administration officials said.